Skip to main content
ACTU
NASDAQ Life Sciences

Actuate Gets Nasdaq Bid-Price Notice, 180 Days to Reach $1.00

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.335
Mkt Cap
$8.047M
52W Low
$0.33
52W High
$7.9
52W Position info
1.5% above low
Off High info
96% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ACTU is trading near its 52-week low of $0.33 (1.5% above the low).

Summary

Actuate received a Nasdaq minimum bid price deficiency notice on October 28, 2026, giving it until April 26, 2027 to hold a $1.00 bid for 10 consecutive days — a second listing deficiency alongside the pending MVLS notice.


Key Events · Legal and Risk Events · ACTU

  • Nasdaq Bid-Price Deficiency Notice

    On October 28, 2026 Nasdaq notified Actuate that its common stock closed below the $1.00 minimum bid price for 30 consecutive business days, breaching Listing Rule 5450(a)(1).

  • 180-Day Cure Window to April 26, 2027

    The company has until April 26, 2027 to close at $1.00 or above for a minimum of 10 consecutive business days; a second 180-day period requires transferring to the Nasdaq Capital Market and meeting its initial listing standards.

  • Second Listing Deficiency Already Pending

    A separate July 15, 2026 notice for failing the minimum market value of listed securities requirement gives Actuate until January 11, 2027 to cure; the new bid-price notice does not extend that deadline.

  • Cure Likely Requires Reverse Split

    At $0.3351 the stock sits about two-thirds below the $1.00 threshold, so regaining compliance would most likely require a reverse stock split, layered on the 30,985,900 shares and 15,492,950 warrants issued in the offering closed October 28, 2026.


Analysis · ACTU · Life Sciences

Actuate closed below $1.00 for 30 straight business days and now has until April 26, 2027 to get its bid back above $1.00 for at least 10 consecutive days. This is a second, separate listing deficiency stacked on the MVLS notice received July 15, 2026 (deadline January 11, 2027), so the company is fighting two Nasdaq fronts at once. The stock trades at $0.3351, roughly a third of the required bid, meaning a reverse split is the most plausible cure — and that would come on top of the 30,985,900 shares and 15,492,950 warrants just issued in the $11.0 million offering closed October 28. Failure to cure leads to delisting.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACTU was trading at $0.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8M. The 52-week trading range was $0.33 to $7.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACTU - Latest Insights

ACTU
Nov 13, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.2853
Real-time Price: $0.300 info
Change: +$0.0147 (+5%) info
Market Cap: $15.692M info
ACTU
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2853
Real-time Price: $0.300 info
Change: +$0.0147 (+5%) info
Market Cap: $15.692M info
ACTU
Oct 28, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3833
Real-time Price: $0.300 info
Change: -$0.0833 (-22%) info
Market Cap: $15.692M info
ACTU
Oct 28, 2026, 8:00 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.370
Real-time Price: $0.300 info
Change: -$0.070 (-19%) info
Market Cap: $15.692M info
ACTU
Oct 27, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.4279
Real-time Price: $0.300 info
Change: -$0.1279 (-30%) info
Market Cap: $15.692M info